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prognostic value for 1-year mortality independently of successful TAVR (p0.024 and
p0.012 respectively).
Conclusions: Thus pre- and postinterventional hscTnT levels demonstrate preserved
longterm prognostic value in patients with severe aortic stenosis and may reflect a
mortality risk independently of successful TAVR.
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Background: Chronic obstructive pulmonary disease (COPD) has been associated with
higher mortality following transcatheter aortic valve implantation (TAVI), but no data
exist on the factors determining poorer outcomes and functional status improvement in
these patients.
Methods: A total of 210 consecutive patients (29.5% COPD) who underwent TAVI were
studied. Baseline, procedural characteristics and follow-up (median of 12 [6-24] months)
data were prospectively collected. Functional status, as evaluated by NYHA class, Duke
Activity Status Index (DASI) and 6-minute walking test (6MWT), were performed at
baseline and at 6-12 months.
Results: COPD patients were younger, more frequently male and had a history of
smoking, peripheral vascular disease and diabetes mellitus. Survival rates at 1 year after
TAVI were 66% in COPD versus 85% in no-COPD patients (p0.002). In multivariate
analysis, COPD was an independent predictor of cumulative mortality following TAVI
[HR: 2.49, 95% CI: 1.38-4.48, p0.003]. Among COPD patients, a shorter distance in the
pre-procedure 6MWT predicted cumulative mortality [HR: 1.25 for each decrease of
20 m, 95% CI: 1.05-1.49, p0.014], whereas poorer baseline spirometry results (FEV1)
determined a higher rate of periprocedural pulmonary complications [OR: 1.44 for each
decrease of 5%, 95% CI: 1.03-2.0, p0.031]. Baseline FEV1 60% of predicted and a
distance 150 m in the 6MWT best determined the occurrence of periprocedural
pulmonary complications and midterm mortality, respectively. A significant improvement
in functional status was observed following TAVI (p0.001 for changes in NYHA class,
DASI and 6MWT), without differences in the degree of functional improvement between
COPD and no-COPD patients (pNS between groups for changes in NYHA, DASI and
6MWT).
Conclusions: COPD was associated with a higher rate of mortality at midterm follow-up.
Among COPD patients, a higher degree of airway obstruction and a lower exercise
capacity determined a higher risk for pulmonary complications and mortality, respec-
tively. In addition, COPD patients who survived after TAVI exhibited similar improve-
ments in functional status as the rest of the study population.
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Background: Normal aortic and mitral valves function in a reciprocal interdependent
fashion. We hypothesized that the mitral valve function would be affected by severe aortic
stenosis (AS) and that its function would remain altered after transcatheter aortic valve
implantation (TAVI). Using three-dimensional (3D) echocardiography, we studied
aortic-mitral coupling in AS patients undergoing TAVI and compared them to patients
without AS.
Methods: 3D transesophageal echocardiography (Philips) was performed on 38 patients:
16 controls and 22 with severe AS, studied pre- and post-TAVI. Custom software tracked
the aortic and mitral annuli (AA, MA), allowing automated measurements of AA and MA
morphology, angle and motion throughout the cardiac cycle.
Results: Compared to controls, pre-TAVI patients had significantly reduced MA
displacement, MA and AA areas (Table). Post-TAVI, MA displacement, MA and AA
areas remained reduced. AA-MA angle was significantly wider at end-systole in
pre-TAVI patients and became wider throughout the cardiac cycle post-TAVI. There was
no difference in MA or AA dynamics between pre-TAVI patients with mild versus those
with moderate-severe MA calcium, or between Edwards-Sapien and Medtronic Cor-
eValve patients. A trend to reduced MA area was seen in those with moderate-severe MA
calcium post-TAVI.
Controls Pre-TAVI Post-TAVI
(N16) (N22) (N22)
Aortic annulus area
Maximum AoA area (during
systole), cm sq.
5.3	1.1 4.5	1.1 3.3	0.6#
Minimum AoA area, (during
diastole) cm sq.
4.2	1.1 3.7	1.3 3.0	0.6#
Mitral annulus area
Maximum MA area (during
diastole), cm sq
10.7	2.1 8.5	2.0 8.1	1.9
Minimum MA area (during systole),
cm sq.
9.0	2.1 7.2	1.8 6.8	1.8
Mitral annular height
Maximum MA height, mm 10.1	2.2 8.0	2.7 7.6	2.4
Mitral annular motion
MA longitudinal displacement
velocity, mm/s
1.8	0.5 1.0	0.5 1.1	0.5
MA longitudinal displacement, mm 7.8	3.2 5.4	2.3 5.8	2.1
Aortic-mitral annular angle
Maximum Ao-MA angle, degree 122	19 129	20 136	19
Minimum Ao-MA angle, degree 98	16 113	17* 119	20
data presented as mean	sd; p0.05 compared to Controls; †p0.1 compared to
Controls; #p0.05 compared to Pre-TAVI
Conclusions: This study is the first to demonstrate that the effect of severe degenerative
AS extends to a secondary, ‘unaffected’ valve, the mitral valve, due to calcification in the
aortic-mitral fibrous continuity. TAVI does not result in recovery of mitral valve function
as the prosthetic ring compresses the calcified aortic valve into the aortic-mitral fibrous
continuity. These changes not only provide insight into a possible mechanism for
prosthetic aortic valve failure, but also have implications in the future development of
TAVI valves and possible need for mitral valve assessment before and after the procedure.
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Background: Prosthesis patient mismatch (PPM) is an independent predictor of
mortality post aortic valve replacement. We sought to determine if 3-dimensional aortic
annular measurements by multi-detector computed tomography (MDCT) are predictive of
PPM post transcatheter aortic valve replacement (TAVR).
Methods: 128 patients underwent MDCT then TAVR. Moderate PPM was defined as an
indexed effective orifice area 0.85 cm2/m2 and severe 0.65 cm2/m2. MDCT annular
measurements (area, short and long axis) were compared with the size of the selected
transcatheter heart valve (THV) to obtain a) the difference between prosthesis size and CT
measured mean annular diameter, and b) the percentage of undersizing (calculated as 100
* (MDCT annular area  THV nominal area)/ THV nominal area). Additionally, the
MDCT annular area was indexed to body surface area. These measures were evaluated as
potential predictors of PPM.
Results: On discharge echocardiography, 42.2% (54/128) had moderate PPM and 9.4%
(12/128) severe PPM. Procedural characteristics and in-hospital outcomes did not differ
between those with or without PPM. THV undersizing of the mean diameter was not
predictive of moderate (OR 0.84, 95% CI 0.65 – 1.07, p0.16, AUC 0.58) or severe PPM
(OR 0.84, 95% CI 0.55-2.1, p 0.79, AUC 0.59). THV undersizing of annular area was
not predictive of moderate (OR 0.96, 95% CI 0.80-1.16, p0.69, AUC 0.52) or severe
PPM (OR 0.95, 95% CI 0.70-1.30, p0.74, AUC 0.53). Indexed MDCT annular area was
predictive of PPM (OR 0.24, 95% CI 0.10 – 0.59, p  0.001, AUC 0.66).
Conclusions: Severe PPM is not infrequent post TAVR. The etiology of PPM is not
related to undersing of the THV relative to 3-D aortic annular size by MDCT. Indexed
MDCT annular area is moderately predictive of PPM.
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